Manufacturing, Biosimilars and Biobetters

February 6th 2025

Process consistency and robustness, analytical excellence, and regulatory compliance are essential in the scale-up of biosimilars.

June 6th 2024

Biosimilar analytical assessments focus on demonstrating biosimilarity and interchangeability with the reference biologic.

July 27th 2023

Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.

June 12th 2023

World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.